Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies. The post Why Epic Is Launching a Prescription Price Comparison Tool appeared first on MedCity News.
City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders. The post City Therapeutics’ Upsized IPO Raises $200M…
There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable. The post The Impending End of Cross-Subsidization appeared first on MedCity News.
The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together. The post How AI Is Connecting MedTech’s Data Without Compromising Compliance appeared first on MedCity News.
Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members. The post Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal appeared first on MedCity News.
Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with companies such as Bayer and AbbVie. The post AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D appeared first on…
What is needed is a fundamentally different operating model for primary care, one designed around continuous engagement rather than episodic encounters. The post Why the Future of Healthcare Depends on Reinventing Primary Care Access appeared first on MedCity News.
[Sponsored] Panelists in the webinar, sponsored by Inovalon, will explore how near real-time surveillance, smart risk prioritization, and closed-loop intervention are shifting stewardship programs to proactive, technology-enabled decision-making that lets pharmacists work at the top of their license. The post The Role of Hospital Stewardship to Improve Outcomes and Manage Costs appeared first on MedCity…
HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy. The post HealthTap Introduces Virtual Primary Care Program for DME Suppliers appeared first on MedCity News.
Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue yet another deal for a rare disease asset. The post Ultragenyx Rare Disease Voucher Sales Secure $413M for…